Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Polymorphisms Influence the Expression of the Fas and FasL Genes in COVID-19
- dos Santos Brito W.R. , et al.
2. Mechanism of cytotoxic T lymphocyte－derived exosomes inhibiting hepatic stellate cell activation
- Qin C. , et al.
3. Plasma Levels of sFas-sFasL and FASL Gene Expression Are Associated with Tuberculosis
- Souza I.d.P. , et al.
5. TNF-related apoptosis-inducing ligand (TRAIL), death receptor (DR4) and Fas gene polymorphisms associated with liver cirrhosis in hepatitis C infected patients
- Talaat R.M. , et al.
6. The potential role of HLA-G in the pathogenesis of HBV infection: Immunosuppressive or immunoprotective?
- Rashidi S. , et al.
8. Fas and FasL promoter polymorphisms and susceptibility to HBV infection: A systematic review and meta-analysis
- Mohammadi A. , et al.
9. FAS and FASL polymorphisms and susceptibility to hepatitis B virus infection in Javanese individuals
- Prasetyo A. , et al.
10. Inhibitory effect of Patrinia on BRL-3A cell apoptosis through the TLR4/PI3K/AKT/GSK3β and TLR4/P38/JNK signaling pathways
- Chen X. , et al.
11. Status of FAS and FAS ligand gene polymorphisms in patients with breast cancer in Northeastern Iran
- Jalali S.A. , et al.
12. The relationship of fas promoter polymorphisms and breast cancer risk in north-west of Iran: A haplotype and in silico analysis
- Dastmalchi N. , et al.